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Abstract Valosin-containing protein (VCP) was previ-
ously shown to exhibit high expression in colorectal cancer
(CRC) tissues as compared with that in normal tissues;
however, the role of VCP in human CRC cells has
remained to be elucidated. Two colorectal cancer cell lines
HCT116 and RKO were used in the experiment. We
introduced lentiviral constructs expressing VCP to infect
RKO cells and lenti-shRNA targeting VCP into HCT116
cells, respectively. Cell proliferation, invasion, apoptosis,
and cell cycle arrest were subsequently examined by MTT
assay, transwell chamber assay, flow cytometry, and
western blot analysis, respectively. Furthermore, a subcu-
taneous tumor mouse model and lung metastasis model
was used to investigate the effects of VCP on the growth
and metastasis of CRC cells in vivo. VCP knockdown was
shown to inhibit cell proliferation, chemoresistance and
invasion, and induce apoptosis in the HCT116 CRC cells,
whereas VCP over-expression suppressed apoptosis and
chemoresponse, promoted proliferation and invasion of the
RKO CRC cells. In addition, in the subcutaneous tumor
and lung metastasis mouse model, VCP knockdown in
HCT116 cells suppressed carcinogenesis and metastasis
in vivo. The findings of the present study indicated that
VCP is very important for the proliferation and metastasis
of CRC; therefore, targeting VCP and its downstream tar-
gets may represent novel therapies for the treatment of
CRC.
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Introduction
Colorectal cancer (CRC) is the third most common cancer
and is tightly linked to lifestyle. Indeed, high-income
countries such as the USA, New Zealand, Japan, and
Western Europe show an incidence for CRC 10-fold higher
than low-income and middle-income countries (Africa,
South America, and South Asia) [1]. The disease typically
develops over many years via a sequence of genetic
changes, which is known as the adenoma–carcinoma
sequence [2]. Every year, more than 1 million new cases
are diagnosed. Although much effort has centered on
probing the pathogenesis of the disease, the molecular
mechanisms underlying the process are still largely
unknown [3].
Valosin-containing protein (VCP) belongs to the AAA
family (ATPase with multiple cellular activities) [4]. It is
one of the most abundant proteins in eukaryotic cells and
can interact with more than 30 different cellular proteins
with various functions, including morphology alteration of
nuclear and golgi membranes, transcriptional regulation,
membrane fusion, programed cell death, ubiqutin/protea-
some-dependent protein degradation, and ER-associated
degradation [5–8]. In addition, VCP is associated with the
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various cellular pathologies and disease states including
neurodegenerative disorders [9, 10], pulmonary conditions
[11], and other protein misfolding disorders [12, 13].
Additionally, clinical studies have identified a correlation
between elevated VCP expression and the progression,
prognosis, and metastatic potential of esophageal carci-
noma [14], colorectal carcinoma [15], and prostate cancer
[16]. Although Yamamoto S et al. demonstrated that VCP
is upregulated and high VCP expression levels are asso-
ciated with poor prognosis of CRC patients [15], the
detailed function of VCP in human CRC remains unclear.
Signal transducers and activators of transcription
(STATs) are cytoplasmic transcription factors, and STATs
are key mediators of cytokine and growth factor signaling
pathways [17]. STATs are latent transcription factors
activated by phosphorylation of a conserved tyrosine resi-
due. Experimental and clinical data have revealed the
oncogenic potential of STAT3 through over-expression and
constitutive activation in a variety of human malignancies
[18]. When phosphorylated at tyrosine705, STAT3 under-
goes translocation from the cytosol to the nucleus, where it
functions as a pivotal transcription factor upregulating gene
transcription [19]. Increasing evidences suggest that
STAT3 signaling is aberrant in human CRC cells and CRC
tissues with prolonged and sustained STAT-3 phosphory-
lation [20, 21]. So, STAT3 is a promising candidate for
CRC targeted therapy.
In the present study, we demonstrate that VCP promotes
proliferation and metastasis in CRC, and VCP knockdown
induces G1 phase arrest and apoptosis in CRC through
STAT3 dephosphorylation, both in vitro and in vivo.
Materials and methods
Cell lines and regents
HCT116 and RKO CRC cell lines were obtained from
Shanghai Bioleaf Biotech Co., Ltd (Shanghai, China).
HCT116 and RKO were p53 wild-type cells. HCT116 was
obtained from a male colonic carcinoma patient [22]. RKO
was obtained from a poorly differentiated colon carcinoma
patient [23]. CRC cell lines were incubated in DMEM
(Gibco, Invitrogen Company, Grand Island, NY) contain-
ing 10 % heat-inactivated fetal bovine serum supplemented
with 1 % penicillin–streptomycin solution (Gibco) at 37 C
in a humidified atmosphere of 5 % CO2. 5-FU was pur-
chased from Sigma-Aldrich (St. Louis, MO).
Lentiviral infection
Human lenti-VCP, lenti-shVCP, lenti-vector control, and
lenti-shNC were designed and purchased from GeneChem
Technologies (Shanghai, China). The transfection was
performed according to standard procedures. Following
lentiviral infection, single-cell clonal isolates were selected
in the presence of puromycin for 2–4 weeks.
MTT assay
CRC cells were seeded in 96-well plates at a density of
2 9 103 cells/well. After 24, 48, and 72 h, the medium was
replaced with 200 lL of 10 % FBS supplemented DMEM
containing 0.5 mg/mL MTT (Sigma-Aldrich), and cells
were incubated in the CO2 incubator at 37 C for 4 h.
Medium was removed, the reduced MTT was solubilized in
100 lL per well of DMSO (Sigma-Aldrich), and measured
absorbance at 570 nm by a IMARK microplate reader
(Bio-Rad, Hercules, CA, USA).
Western blot
For preparing total cell lysates, cells were lysed in lysis
buffer (Invitrogen), incubated on ice for 30 min and cen-
trifuged for 20 min to remove cell debris. Total cell lysate
was subjected to SDS-polyacrylamide gel electrophoresis.
The proteins were then electro-transferred to polyvinyli-
dene difluoride membrane (Millipore, Billerica, MA) and
incubated overnight with antibodies at 4 C. Subsequently,
the membranes were incubated with secondary antibodies
for 1 h at room temperature and the signal was detected
using an enhanced chemiluminescence detection kit
(Pierce, Rockford, IL). The primary antibodies: VCP, Ki-
67, E-cadherin, N-cadherin, and vimentin were purchased
from Abcam (Cambridge, MA). Cyclin D1, CDK4, cyclin
E, CDK2, PCNA, Bcl-2, Bax, Bcl-xL, and actin were
purchased from Santa Cruz Biotechnology (Dallas, Texas).
STAT3, p-STAT3 (Tyr705), p21, cleaved-caspase-3, and
cleaved-PARP were purchased from Cell Signaling Tech-
nology (Danvers, MA). The secondary antibodies, anti-
mouse IgG-HRP, and antirabbit IgG-HRP were purchased
from Santa Cruz Biotechnology.
Cell cycle and apoptosis analysis
Cell cycle and apoptosis assays were performed as
described elsewhere [24]. Annexin V–FITC apoptosis kit
and cell cycle analysis kit were purchased from Becton–
Dickinson, San Diego, CA, USA. Cells were analyzed on a
Becton–Dickinson FACS Caliber flow cytometer (BD
Biosciences).
Immunohistochemistry analysis
Immunohistochemistry was performed using Ki-67,
cleaved-caspase-3, and CD31 antibodies. In brief, tissue
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sections were deparaffinized in xylene and rehydrated with
ethanol. Tissue sections were then preincubated with 10 %
normal goat serum in PBS (pH 7.5) followed with incu-
bation with primary antibody overnight at 4 C. Tissue
sections were then stained with biotinylated secondary
antibody (Vector lab, Burlingame, CA) for 1 h at room
temperature, followed by the Vectastain Elite ABC reagent
(Vector lab) for 30 min. The peroxidase reaction was
developed with diaminobenzidine (DAB kit; Vector lab)
and the slides were counterstained with hematoxylin
(Sigma).
Cell invasion assay
Invasion was measured using 24-well BioCoat cell culture
inserts (BD Biosciences) with an 8-lm-porosity poly-
ethylene terephthalate membrane coated with Matrigel
Basement Membrane Matrix (BD Biosciences). The inva-
sion assay was performed as previously described [25].
Immunofluorescence
Briefly, cells seeded on coverslips were fixed with 4 % (w/
v) paraformaldehyde (Sigma) for 10 min and permeabi-
lized with 0.1 % (v/v) Triton X-100 for 5 min at room
temperature. The cells were then incubated overnight with
primary antibodies at 4 C, followed by incubation with
fluorescent secondary antibody (invitrogen) for 1 h at room
temperature. After final washes with PBS, the coverslips
were mounted using an antifade mounting solution con-
taining 40,6-diamidino-2-phenylindole (DAPI; Vector lab)
and images were examined and captured.
Subcutaneous CRC experiments
The study was approved by the ethics committee of The
First Affiliated Hospital of Harbin Medical University
(Harbin, China). The average weight 20 g, 6-week-old
female athymic nude mice (BALBc nu/nu; Experimental
Animal Laboratories, Shanghai, China) were used in all
experiments (8 mice for each group). The animals were
maintained in a specific pathogenfree environment. The
mice were fed with autoclaved food and water. The
animal room was kept at 20–22 C under a 12-hour
light/dark cycle. Each mouse was injected subcuta-
neously with stably transfected CRC cells and control
cells (4 9 106). The volume of tumors were monitored
and measured by vernier caliper, and tumor volume
(mm3) was calculated using the standard formula:
length 9 width 9 height 9 0.5236. All mice sacrificed
by CO2 six weeks after implantation, snap-frozen and
paraffin-embedded tumor tissue blocks were obtained for
further analysis.
In vivo invasive assay
To evaluate long-distance lung metastasis, CRC cells
(1 9 106/0.2 mL) were injected into nude mice
(n = 8/group) by way of tail vein to imitate lung metas-
tasis. Mice were sacrificed at 8 weeks, and the lung
metastases were confirmed by H&E staining.
Statistical analysis
Statistical analysis was performed with the GraphPad
Prism software package (v. 4.02; San Diego, CA, USA) or
SPSS 16.0 software (Chicago, IL, USA). Values are
expressed as the mean ± SD. Comparisons between mul-
tiple groups were made using a one-way analysis of vari-
ance, followed by Dunnet’s t test. P\ 0.05 was considered
to indicate a statistically significant difference between
values.
Results
VCP promotes cell proliferation and VCP
knockdown induces G1 phase arrest in CRC cell
lines
As shown in Fig. 1a and Supplementary Fig. 1a, the basal
level of VCP is higher in HCT116 than in RKO cells. So,
we chose these two cell lines with different VCP basal
levels. To determine whether VCP expression had an effect
on CRC cell progression, we generated lentiviral constructs
expressing VCP to infect RKO cells, and we introduced
lenti-shRNA targeting VCP into HCT116 cells. The levels
of VCP after transfection were determined by western blot
(Fig. 1a).
To determine whether there was an association between
VCP expression and CRC cell proliferation, an MTT assay
was performed. RKO cells transfected with lenti-VCP
exhibited a marked increase in cell proliferation as com-
pared with that in the control group (Fig. 1b). In addition,
there was a significant decrease in cell proliferation in the
HCT116 cells transfected with shVCP (Fig. 1b). Flow
cytometry revealed an increase in the number of lenti-
VCP-transfected RKO cells in S phase, as compared with
that in the control group (Fig. 1c, d). Conversely, there was
an increase in the number of shVCP-transfected HCT116
cells in G1 phase (Fig. 1c, d). Concurrently, the expression
levels of cell cycle arrest-associated proteins were exam-
ined by western blot analysis (Fig. 1e and Supplementary
Fig. 1b). The expression of p21 increased in shVCP-
transfected HCT116 cells, and p21 level decreased in lenti-
VCP-transfected RKO cells. In addition, the protein
expression levels of cyclin D1, cyclin E, CDK2, CDK4, Ki-
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67, and PCNA were higher in lenti-VCP-transfected RKO
cells, as compared with those in control cells. Conversely,
the expression levels were lower in shVCP-transfected
HCT116 cells as compared with those in control cells,
which was concordant with the results from the MTT and
cell cycle assays. These results suggested that VCP may
promote cell proliferation and VCP knockdown induce G1
cell cycle arrest in CRC cells.
VCP knockdown increases the percentage
of apoptotic CRC cells, and promotes
chemoresponse to 5-FU in CRC cells
The number of apoptotic CRC cells was measured using an
Annexin V/PI Apoptosis Detection kit and flow cytometry
at three days posttransfection. shVCP-transfected HCT116
cells exhibited a relatively high rate of cell apoptosis as
compared with control cells (Fig. 2a, b). Conversely, RKO
cells transfected with lenti-VCP exhibited a relatively low
rate of apoptosis as compared with that of the control cells
(Fig. 2a, b).
In addition, western blot analysis was performed to
determine the expression levels of the following apoptosis-
associated proteins in CRC cells: Bcl-2, Bax, Bcl-xL,
cleaved-PARP, cleaved-caspase-3, STAT3, and p-STAT3.
At three days posttransfection, the expression levels of Bcl-
2 and Bcl-xL were significantly decreased in the shVCP-
transfected HCT116 cells as compared with control cells,
whereas the expression levels of Bax, cleaved-PARP, and
cleaved-caspase-3 were increased. Furthermore, shVCP-
transfected HCT116 cells exhibited lower expression levels
of p-STAT3, whereas the expression levels of total STAT3
were unaffected (Fig. 2c and Supplementary Fig. 1c).
Conversely, three days posttransfection, Bcl-2, Bcl-xL, and
p-STAT3 expression were upregulated, and the expression
levels of Bax, cleaved-PARP, and cleaved-caspase-3 were
decreased in the lenti-VCP-transfected RKO cells (Fig. 2c
and Supplementary Fig. 1c). These results indicated that
the VCP knockdown-dependent increase in the rate of CRC
cell apoptosis may be partially mediated by regulation of
Bcl-2, Bcl-xL, Bax, cleaved-PARP, cleaved-caspase-3, and
p-STAT3.
Fig. 1 Effects of VCP on cell proliferation, cell cycle-associated
protein expression, and cell cycle progression in HCT116 and RKO
cells. a The expression level of VCP was detected by western blot
after lenti-VCP or shVCP transfection. Actin was used as the internal
control. Western blot was repeated three times. b Effects of VCP
knockdown and over-expression on the proliferation of CRC cells.
Cell proliferation after transfection was assessed by MTT assay.
Values are expressed as the mean ± SD of three independent
experiments. c and d Representative images of the cell cycle analysis
of indicated CRC cells. VCP knockdown induced G1 cell cycle arrest
in HCT116 cells, and VCP over-expression increased in the number
of RKO cells in S phase. The percentage of cells in each phase of the
cell cycle is presented as the mean ± SD from three independent
experiments. e CRC cells were subjected to western blot analysis for
the indicated protein expression. Actin was used as the internal
control. Western blot was repeated three times
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To investigate the potential role of VCP in CRCs, the
effect of VCP on the cellular response toward chemother-
apeutic agents was determined in HCT116 and RKO cells.
Notably, lenti-VCP transfection markedly reduced 5-FU-
induced apoptosis in RKO cells, and VCP knockdown
markedly increased 5-FU-induced apoptosis in HCT116
cells (Fig. 2d). The effect of VCP on 5-FU-mediated
apoptosis was further clearly demonstrated by the detection
of cleaved-PARP and cleaved-caspase-3 in CRC cells
transfected with lenti-VCP or shVCP (Fig. 2e and Sup-
plementary Fig. 1d).
VCP promotes CRC growth in vivo
The present study further examined the effects of VCP on
CRC growth by establishing HCT116 and RKO xenograft
nude mouse CRC models. Mice injected with HCT116
cells which were transfected with shVCP exhibited
significantly smaller tumors as compared with control
group (Fig. 3a). Conversely, Mice injected with RKO cells
over-expressing VCP exhibited significantly larger tumors
as compared with control group (Fig. 3a). Immunohisto-
chemical analysis was used to stain Ki-67 to determine cell
proliferation; cleaved-caspase-3 to detect apoptotic cells;
and CD31 to detect tumor microvessels. There were fewer
Ki-67 positive cells, more apoptotic cells, and fewer CD31-
stained vessels in tumors with VCP knockdown, as com-
pared with the control tumors (Fig. 3b, c). In tumors over-
expressing VCP, there were more Ki-67 positive cells and
CD31-stained vessels as compared with the control tumors
(Fig. 3b, c). In addition, western blot showed the levels of
p-STAT3, cyclin D1, cyclin E, CDK2, CDK4, PCNA, Ki-
67, Bcl-2, and Bcl-xL were decreased in the VCP knock-
down tumors, and increased in the VCP over-expressing
tumors (Fig. 3d and Supplementary Fig. 1e). In addition,
the expression levels of p21, Bax, cleaved-PARP, and
Fig. 2 VCP knockdown induces apoptosis in CRC cells and
promotes 5-FU-induced apoptosis in CRC cells. a and b Flow
cytometry results of annexin V-PI staining of CRC cells following
transfection with lenti-VCP or shVCP. An increase in the percentage
of apoptotic cells following transfection with shVCP is shown. Values
are expressed as the mean ± SD of three independent experiments.
c Changes in protein expression levels of anti- or proapoptotic
proteins following transfection with lenti-VCP or shVCP. Actin was
used as the internal control. Western blot was repeated three times.
d The percentage of apoptotic cells was determined by annexin V-PI
staining after transfection and 5-FU (500 lM) treatment. Values are
expressed as the mean ± SD of three independent experiments.
e Indicated protein expression was detected by western blot after
transfection and 5-FU (500 lM) treatment. Actin was used as the
internal control. Western blot was repeated three times
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cleaved-caspase-3 were increased in the VCP knockdown
tumors, and decreased in the VCP over-expressing tumors
(Fig. 3d and Supplementary Fig. 1e). These results indicate
the functional significance of VCP, and its high propensity
to promote proliferation in CRC.
VCP knockdown inhibits CRC metastasis in vitro
and in vivo
The association between VCP expression and CRC cell
invasion was detected using a Matrigel invasion assay. The
number of invaded shVCP-transfected HCT116 cells was
significantly lower as compared with control group
(Fig. 4a, b), thus suggesting that the percentage of invaded
cells decreased in VCP knockdown cells. Furthermore, the
invasiveness of lenti-VCP-transfected RKO cells was
increased as compared with that of control cells (Fig. 4a,
b).
The epithelial–mesenchymal transition (EMT) associ-
ated markers vimentin, N-cadherin, and E-cadherin have
essential roles in the invasion of tumor cells. Therefore, the
present study examined the expression levels of vimentin,
Fig. 3 VCP promotes proliferation of CRC in vivo. a Representative
images of xenograft tumors were shown for the indicated CRC cells.
The histogram showed the size of tumors for the indicated CRC cells.
Values are expressed as the mean ± SD of experiments performed in
triplicate. b Tumors from the different groups were immunostained
for cleaved-caspase-3, CD31 and Ki-67. Images are representative of
three independent experiments. c Quantification of immunostaining in
(b). CD31-stained microvessels were counted to record microvessel
density, apoptotic cells were counted to give the apoptosis index and
cells expressing Ki-67 were counted to calculate the Ki-67 positive
cells. d Western blot was performed to detect the protein expression
levels of the indicated molecules from tumor samples. Actin was used
as the internal control. Western blot was repeated three times
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N-cadherin, and E-cadherin in CRC cells by western blot.
The protein expression levels of vimentin and N-cadherin
were downregulated in shVCP-transfected HCT116 cells as
compared with control group, and E-cadherin expression
levels were upregulated (Fig. 4c and Supplementary
Fig. 1f). In addition, in lenti-VCP-transfected RKO cells,
the expression levels of vimentin and N-cadherin were
significantly increased, and expression levels of E-cadherin
were significantly decreased (Fig. 4c and Supplementary
Fig. 1f). As shown by immunofluorescence (Fig. 4d),
transfection with lenti-VCP markedly increased N-cadherin
and vimentin expression in RKO cells, and transfection
with shVCP significantly decreased N-cadherin and
vimentin expression in HCT116 cells, which was in con-
cordance with the results of the western blot analysis.
These results suggested that VCP may promote CRC cell
invasion in vitro.
Next, we tested whether VCP could promote metastasis
in vivo. The tumor volume, number of nodules, and the
incidence of lung metastasis were drastically decreased in
VCP knockdown HCT116 cells. The tumor volume,
number of nodules, and the incidence of lung metastasis
were significantly increased in RKO cells which were
transfected with lenti-VCP (Fig. 4e).
Discussion
VCP plays a key role in the ubiquitin-dependent protea-
some degradation pathway [8]. In particular, VCP inhibits
apoptosis after stimulation with cytokines such as tumor
necrosis factor via degradation of inhibitor rBa, an inhi-
bitor of nuclear factor-rB (NF-rB). Murine osteosarcoma
cells transfected with the VCP gene exhibited constant
activation of NF-rB, rapid degradation of phosphorylated-
inhibitor rBa, decreased apoptosis rates after tumor
necrosis factor a stimulation, and increased metastatic
potential [7]. VCP is overexpressed in many solid tumors,
including prostate and pancreatic cancers [16, 26], eso-
phageal carcinomas [14], and osteosarcoma [7]. Recent
studies have also indicated that VCP expression may be an
independent prognostic factor for overall survival in non-
small cell lung carcinoma [27, 28]. Yamamoto S et al.
reported that the level of VCP is associated with the
prognosis of CRC [15]. However, the exact mechanisms
underlying the effects of VCP on CRC are yet to be elu-
cidated. Therefore, it is required to study the role of VCP in
the regulation of CRC cell growth, survival, and invasion.
In order to test the function of VCP in CRC, shVCP was
transfected into HCT116 cells. In the present study, MTT,
flow cytometric and invasive assays demonstrated that
downregulation of VCP resulted in the inhibition of cell
proliferation, induction of apoptosis, and suppression of
invasiveness. These results suggested that VCP has an
important role in the regulation of tumorigenesis of CRC.
Further evidence regarding this finding was obtained from
RKO cells with VCP over-expression. Transfection of
RKO cells with lenti-VCP was used to upregulate VCP
expression, which resulted in increased cell proliferation
and invasiveness, as well as decreased levels of apoptosis.
VCP knockdown also markedly increased 5-FU-induced
apoptosis in HCT116 cells, and over-expression of VCP
promotes chemoresistance in cultured RKO cells. There-
fore, VCP could be an important factor contributing to the
chemoresistance in CRCs. Furthermore, in a subcutaneous
mouse tumor model, VCP knockdown significantly
reduced subcutaneous tumor growth, and VCP over-ex-
pression promoted subcutaneous tumor growth.
To provide further evidence regarding the mechanisms
underlying the effects of VCP on CRC cells, the present
study examined the expression levels of proteins associated
with CRC cell proliferation (p21, cyclin D1, CDK4, cyclin
E, CDK2, Ki-67, and PCNA) and apoptosis (Bcl-2/Bax,
Bcl-xL, cleaved-PARP, cleaved-caspase-3, p-STAT3, and
STAT3) by western blot analysis. The expression of p21
increased after shVCP transfection and decreased after
lenti-VCP transfection. The protein expression levels of
cyclin D1, CDK4, cyclin E, CDK2, and Ki-67, a biological
tumor marker that indicates changes in tumor proliferation,
were reduced in the shVCP-transfected HCT116 cells, and
increased in the lenti-VCP transfected RKO cells. In
addition, changes in the expression levels of PCNA,
another well-known proliferation marker, were similar to
those of Ki-67 in the shVCP-transfected HCT116 and the
lenti-VCP transfected RKO cells.
The apoptosis-associated proteins, such as Bcl-2, Bax,
Bcl-xL, cleaved-PARP, and cleaved-caspase-3 were also
detected by western blot analysis. The results of the
present study demonstrated that the upregulation of VCP
induced an increase in the protein expression levels of
Bcl-2, Bcl-xL, and also significantly decreased the
expression levels of Bax, cleaved-PARP, and cleaved-
caspase-3. Downregulation of VCP decreased the levels
of Bcl-2, Bcl-xL, and increased the levels of Bax,
cleaved-PARP, and cleaved-caspase-3. The STAT3 path-
way is important in CRC, and numerous studies have
been performed to demonstrate that the p-STAT3
expression levels were elevated in CRC in vitro and
in vivo, and this expression was revealed to be correlated
with the poor prognosis [20, 21, 29]. The present study
revealed that VCP over-expression also induced STAT3
phosphorylation, whereas it did not affect the expression
of total STAT3. Therefore, the increase in p-STAT3,
together with the increased expression of Bcl-2, may
explain why cells with high VCP expression are resistant
to chemotherapy-induced apoptosis.
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EMT, an absolute requirement for tumor invasion and
metastasis, plays a key role in cancer progression [30, 31].
The present study demonstrated a positive correlation
between vimentin, N-cadherin, and VCP expression, and a
negative correlation between E-cadherin and VCP expres-
sion. These results indicated that the over-expression of
VCP may promote the metastasis of CRC in vitro and
in vivo through modulation of vimentin, N-cadherin, and
E-cadherin.
In conclusion, the present study demonstrated that VCP
may have an important role in the regulation of growth,
chemoresistance, and metastasis of CRC. These findings
indicated that VCP may serve as a potential therapeutic
target in the treatment of CRC.
Compliance with ethical standards
Conflict of interest No potential conflicts of interest were disclosed.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://crea
tivecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were
made.
References
1. Jemal A, Center MM, DeSantis C, Ward EM (2010) Global
patterns of cancer incidence and mortality rates and trends.
Cancer Epidemiol Biomark Prev 19:1893–1907. doi:10.1158/
1055-9965.EPI-10-0437
2. Fearon ER, Vogelstein B (1990) A genetic model for colorectal
tumorigenesis. Cell 61:759–767. doi:10.1016/0092-8674(90)90186-I
3. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013.
CA Cancer J Clin 63:11–30. doi:10.3322/caac.21166
4. Ogura T, Wilkinson AJ (2001) AAA? superfamily ATPases:
common structure–diverse function. Genes Cells 6:575–597.
doi:10.1046/j.1365-2443.2001.00447.x
5. Hetzer M, Meyer HH, Walther TC, Bilbao-Cortes D, Warren G,
Mattaj IW (2001) Distinct AAA-ATPase p97 complexes function
in discrete steps of nuclear assembly. Nat Cell Biol 3:1086–1091.
doi:10.1038/ncb1201-1086
6. Rabouille C, Levine TP, Peters JM, Warren G (1995) An NSF-
like ATPase, p97, and NSF mediate cisternal regrowth from
mitotic Golgi fragments. Cell 82:905–914. doi:10.1016/0092-
8674(95)90270-8
7. Asai T, Tomita Y, Nakatsuka S, Hoshida Y, Myoui A, Yoshikawa
H, Aozasa K (2002) VCP (p97) regulates NFkappaB signaling
pathway, which is important for metastasis of osteosarcoma cell
line. Jpn J Cancer Res 93:296–304
8. Dai RM, Chen E, Longo DL, Gorbea CM, Li CC (1998)
Involvement of valosin-containing protein, an ATPase Co-puri-
fied with IkappaBalpha and 26 S proteasome, in ubiquitin-pro-
teasome-mediated degradation of IkappaBalpha. J Biol Chem
273:3562–3573
9. Hirabayashi M, Inoue K, Tanaka K, Nakadate K, Ohsawa Y,
Kamei Y, Popiel AH, Sinohara A, Iwamatsu A, Kimura Y,
Uchiyama Y, Hori S, Kakizuka A (2001) VCP/p97 in abnormal
protein aggregates, cytoplasmic vacuoles, and cell death, phe-
notypes relevant to neurodegeneration. Cell Death Differ
8:977–984. doi:10.1038/sj.cdd.4400907
10. Ishigaki S, Hishikawa N, Niwa J, Iemura S, Natsume T, Hori S,
Kakizuka A, Tanaka K, Sobue G (2004) Physical and functional
interaction between Dorfin and Valosin-containing protein that
are colocalized in ubiquitylated inclusions in neurodegenerative
disorders. J Biol Chem 279:51376–51385. doi:10.1074/jbc.
M406683200
11. Min T, Bodas M, Mazur S, Vij N (2011) Critical role of pro-
teostasis-imbalance in pathogenesis of COPD and severe
emphysema. J Mol Med 89:577–593. doi:10.1007/s00109-011-
0732-8
12. Vij N (2008) AAA ATPase p97/VCP: cellular functions, disease
and therapeutic potential. J Cell Mol Med 12:2511–2518. doi:10.
1111/j.1582-4934.2008.00462.x
13. Vij N (2011) The case for therapeutic proteostasis modulators.
Expert Opin Ther Targets 15:233–236. doi:10.1517/14728222.
2011.553610
14. Yamamoto S, Tomita Y, Hoshida Y, Iizuka N, Kidogami S,
Miyata H, Takiguchi S, Fujiwara Y, Yasuda T, Yano M, Naka-
mori S, Sakon M, Monden M, Aozasa K (2004) Expression level
of valosin-containing protein (p97) is associated with prognosis
of esophageal carcinoma. Clin Cancer Res 10:5558–5565. doi:10.
1158/1078-0432.CCR-0723-03
15. Yamamoto S, Tomita Y, Hoshida Y, Sakon M, Kameyama M,
Imaoka S, Sekimoto M, Nakamori S, Monden M, Aozasa K
(2004) Expression of valosin-containing protein in colorectal
carcinomas as a predictor for disease recurrence and prognosis.
Clin Cancer Res 10:651–657
16. Tsujimoto Y, Tomita Y, Hoshida Y, Kono T, Oka T, Yamamoto
S, Nonomura N, Okuyama A, Aozasa K (2004) Elevated
expression of valosin-containing protein (p97) is associated with
poor prognosis of prostate cancer. Clin Cancer Res 10:3007–3012
17. Darnell JE Jr (1997) STATs and gene regulation. Science
277:1630–1635
18. Bowman T, Garcia R, Turkson J, Jove R (2000) STATs in
oncogenesis. Oncogene 19:2474–2488. doi:10.1038/sj.onc.
1203527
19. Lu Z, Wang J, Zheng T, Liang Y, Yin D, Song R, Pei T, Pan S,
Jiang H, Liu L (2014) FTY720 inhibits proliferation and
epithelial-mesenchymal transition in cholangiocarcinoma by
inactivating STAT3 signaling. BMC Cancer 14:783. doi:10.1186/
1471-2407-14-783
20. Kusaba T, Nakayama T, Yamazumi K, Yakata Y, Yoshizaki A,
Nagayasu T, Sekine I (2005) Expression of p-STAT3 in human
colorectal adenocarcinoma and adenoma; correlation with
bFig. 4 VCP promotes metastasis of CRC in vitro and in vivo. a and
b Cell invasion experiments demonstrated that transfection with
shVCP significantly inhibited the invasive capacity of HCT116 cells,
and transfection with lenti-VCP promoted the invasive capacity of
RKO cells. Values are expressed as the mean ± SD of experiments
performed in triplicate. c Protein expression levels of N-cadherin,
vimentin, and E-cadherin in shVCP-transfected HCT116 cells and
lenti-VCP transfected RKO cells. Actin was used as the internal
control. Western blot was repeated three times. d Single and merged
images were taken to show immunofluorescence staining of N-cad-
herin (green) and vimentin (red), accompanied by nuclear staining
(blue) with DAPI. e Representative H&E images of lung metastases
were shown for indicated cell lines. The histogram showed the
number of metastatic nodules. The table showed incidence of lung
metastasis in different groups. (Color figure online)
Mol Cell Biochem (2016) 418:189–198 197
123
clinicopathological factors. J Clin Pathol 58:833–838. doi:10.
1136/jcp.2004.023416
21. Rivat C, Rodrigues S, Bruyneel E, Pietu G, Robert A, Redeuilh
G, Bracke M, Gespach C, Attoub S (2005) Implication of STAT3
signaling in human colonic cancer cells during intestinal trefoil
factor 3 (TFF3)–and vascular endothelial growth factor-mediated
cellular invasion and tumor growth. Cancer Res 65:195–202.
doi:10.1158/0008-5472.CAN-65-6-COR
22. Brattain MG, Fine WD, Khaled FM, Thompson J, Brattain DE
(1981) Heterogeneity of malignant cells from a human colonic
carcinoma. Cancer Res 41:1751–1756
23. Brattain MG, Levine AE, Chakrabarty S, Yeoman LC, Willson
JK, Long B (1984) Heterogeneity of human colon carcinoma.
Cancer Metastasis Rev 3:177–191
24. Wang J, Ma Y, Jiang H, Zhu H, Liu L, Sun B, Pan S, Krissansen
GW, Sun X (2011) Overexpression of von Hippel–Lindau protein
synergizes with doxorubicin to suppress hepatocellular carcinoma
in mice. J Hepatol 55:359–368. doi:10.1016/j.jhep.2010.10.043
25. Li X, Yang Q, Yu H, Wu L, Zhao Y, Zhang C, Yue X, Liu Z, Wu
H, Haffty BG, Feng Z, Hu W (2014) LIF promotes tumorigenesis
and metastasis of breast cancer through the AKT-mTOR path-
way. Oncotarget 5:788–801. doi:10.18632/oncotarget.1772
26. Yamamoto S, Tomita Y, Hoshida Y, Nagano H, Dono K, Ume-
shita K, Sakon M, Ishikawa O, Ohigashi H, Nakamori S, Monden
M, Aozasa K (2004) Increased expression of valosin-containing
protein (p97) is associated with lymph node metastasis and
prognosis of pancreatic ductal adenocarcinoma. Ann Surg Oncol
11:165–172
27. Yamamoto S, Tomita Y, Hoshida Y, Iizuka N, Monden M, Iuchi
K, Aozasa K (2004) Expression level of valosin-containing pro-
tein (p97) is correlated with progression and prognosis of non-
small-cell lung carcinoma. Ann Surg Oncol 11:697–704. doi:10.
1245/ASO.2004.10.018
28. Qiu Y, Morii E, Tomita Y, Zhang B, Matsumura A, Kitaichi M,
Okumura M, Aozasa K (2009) Prognostic significance of pre B
cell leukemia transcription factor 2 (PBX2) expression in non-
small cell lung carcinoma. Cancer Sci 100:1198–1209. doi:10.
1111/j.1349-7006.2009.01156.x
29. Kusaba T, Nakayama T, Yamazumi K, Yakata Y, Yoshizaki A,
Inoue K, Nagayasu T, Sekine I (2006) Activation of STAT3 is a
marker of poor prognosis in human colorectal cancer. Oncol Rep
15:1445–1451
30. Kalluri R, Weinberg RA (2009) The basics of epithelial-mes-
enchymal transition. J Clin Invest 119:1420–1428. doi:10.1172/
JCI39104
31. Tsuji T, Ibaragi S, Hu GF (2009) Epithelial-mesenchymal tran-
sition and cell cooperativity in metastasis. Cancer Res
69:7135–7139. doi:10.1158/0008-5472.CAN-09-1618
198 Mol Cell Biochem (2016) 418:189–198
123
